The U.S. Food and Drug Administration approved an updated label for Sun Pharmaceutical Industries Limited's (NSE: SUNPHARMA) UNLOXCYT (cosibelimab-ipdl) based ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE